MARIA NEELEY: Open Payments
NPI 1568866572 · ABERDEEN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 13 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| PFIZER INC. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 2 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Viatris Specialty LLC | 1 | $17 |
Products named: JARDIANCE, OTEZLA, PAXLOVID, REPATHA, XIFAXAN, Ozempic, VOQUEZNA, LYBALVI.
Industry payments across WA — which companies pay providers there.
